Kim Tho Thi Nguyen is a pharmacist who is specialized in Oncology in Los Angeles, California. Patients can reach her at 1441 Eastlake Ave, Los Angeles or contact her on 800-872-2273. Active license number of Kim Tho Thi Nguyen is 80525 for Oncology in California. Kim Tho Thi Nguyen is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Kim Tho Thi Nguyen speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Kim Tho Thi Nguyen
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Female
Location:
1441 Eastlake Ave, Los Angeles, California, 90089-1019
Phone:
800-872-2273
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Kim Tho Thi Nguyen are as mentioned below.
NPI Number:
1205500840
NPI Enumeration Date:
06 Aug, 2021
NPI Last Update On:
06 Aug, 2021
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Kim Tho Thi Nguyen are as mentioned below.
Specialization
License Number
State
Status
Oncology
80525
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1245 Oliva Ct, Duarte, California
Zip:
91010-2775
Phone Number:
626-434-5464
Fax Number:
--
Patients can reach Kim Tho Thi Nguyen at 1441 Eastlake Ave, Los Angeles, California or can call on phone at 800-872-2273.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.